Red-cell aggregation in insulin-dependent diabetics

2016 ◽  
Vol 9 (2) ◽  
pp. 281-295
Author(s):  
A. Othmane ◽  
M. Bitbol ◽  
P. Snabre ◽  
P. Mills ◽  
A. Grimaldi ◽  
...  
1971 ◽  
Vol 3 (6) ◽  
pp. 428-435 ◽  
Author(s):  
P.M. Scholz ◽  
J. Engeset ◽  
N.A. Matheson ◽  
U.F. Gruber

2012 ◽  
Vol 6 (1) ◽  
pp. 44
Author(s):  
Sabita Basu ◽  
Ravneet Kaur ◽  
Gagandeep Kaur ◽  
Paramjit Kaur ◽  
Anita Tahlan

1993 ◽  
Vol 10 (1) ◽  
pp. 21-26 ◽  
Author(s):  
S. MacRury ◽  
S.E. Lennie ◽  
P. McColl ◽  
R. Balendra ◽  
A.C. MacCuish ◽  
...  

1992 ◽  
Vol 12 (4) ◽  
pp. 535-544 ◽  
Author(s):  
G.D.O. Lowe ◽  
A.J. Lee ◽  
A. Rumley ◽  
W.C.S. Smith ◽  
H. Tunstall-Pedoe

1973 ◽  
Vol 19 (1) ◽  
pp. 31-35 ◽  
Author(s):  
J W ten Cate ◽  
N J van Haeringen ◽  
J Gerritsen ◽  
E Glasius

Abstract The effect of O-(β-hydroxyethyl)-rutoside (HR) on human erythrocyte and platelet functions is reported. Only high concentrations of the compound distinctly inhibited red cell and platelet aggregation induced by ADP and epinephrine. Lower concentrations of HR inhibit [14C8]adenosine incorporation into red cells as well as into platelets. Inhibition occurs at both 0°C and 37°C, presumably because diffusion of [14C8]adenosine is hindered. Phosphorylation of [14C8] adenosine by the platelets is not inhibited by HR. The inhibition of red cell aggregation is reversed by washing the cells with plasma. Collectively, these findings indicate an effect of the compound at the site of the membrane, independent of cellular metabolism


Biorheology ◽  
1973 ◽  
Vol 10 (2) ◽  
pp. 213-227 ◽  
Author(s):  
H. Schmid-Schönbein ◽  
G. Gallasch ◽  
E. Volger ◽  
H.J. Klose

Sign in / Sign up

Export Citation Format

Share Document